BiondVax Pharmaceuticals (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products, primarily for treatment of infectious and autoimmune diseases, aims to complement its core focus, nanosized sized antibody (NanoAb) pipeline development, with a comprehensive CDMO (contract development and manufacturing organization) offering. With significant experience including developing its previous flu vaccine […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.